Association of Cystatin C with Metabolic Syndrome and Its Prognostic Performance in Non-ST-Segment Elevation Acute Coronary Syndrome with Preserved Renal Function
Table 5
Univariate and multivariate logistic regression analyses for metabolic syndrome.
Univariate
Multivariate
OR
95% CI
P value
OR
95% CI
P value
Age
0.999
(0.979–1.019)
0.901
Male
1.516
(0.965–2.381)
0.071
1.181
(0.571–2.442)
0.654
BMI
1.41
(1.291–1.541)
<0.001
1.378
(1.242–1.530)
<0.001
Smoking
1.529
(1.013–2.310)
0.043
0.932
(0.498–1.744)
0.825
Hypertension
2.317
(1.504–3.570)
<0.001
2.541
(1.438–4.489)
0.001
Diabetes
4.413
(2.834–6.872)
<0.001
3.208
(1.651–6.232)
0.001
FBG
1.278
(1.151–1.419)
<0.001
1.07
(0.921–1.243)
0.379
TG
1.648
(1.365–1.991)
<0.001
1.277
(1.030–1.584)
0.026
LDL-C
1.132
(0.879–1.457)
0.337
HDL-C
0.048
(0.018–0.133)
<0.001
0.068
(0.018–0.260)
<0.001
High cystatin C
1.944
(1.280–2.952)
0.002
2.299
(1.251–4.225)
0.007
Uric acid
1.005
(1.003–1.007)
<0.001
1.001
(0.997–1.004)
0.659
eGFR-MDRD
0.989
(0.980–0.999)
0.035
0.993
(0.978–1.007)
0.312
CRP
1.012
(0.998–1.026)
0.096
0.996
(0.979–1.014)
0.682
D-dimer
1.005
(0.866–1.166)
0.948
Fibrinogen
0.993
(0.971–1.016)
0.566
High cystatin C is defined as cystatin C concentration > 0.90 mg/L. Abbreviations. BMI: body mass index; FBG: fasting blood glucose; TG: triglyceride; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; eGFR-MDRD: estimated glomerular filtration rate based on MDRD equation; CRP: C-reaction protein.
